Wills Eye Hospital

Tumor-targeted therapy changing game for choroidal melanomaEarly results of a phase Ib/II study investigating light-activated AU-011 (Aura Biosciences) for treatment of small-medium choroidal melanoma show good safety and evidence of efficacy for this novel tumor-targeted therapy.
Bascom Palmer takes top honors in Ophthalmology Times Best Programs SurveyAfter a seven-year hiatus, Ophthalmology Times resumed its Best Programs Survey this fall. While a few new names popped up on the list, Bascom Palmer Eye Institute at the University of Miami Miller School of Medicine, Miami, remained at the top of the Best Overall Program category, followed again by the Wilmer Eye Institute at the Johns Hopkins University School of Medicine, Baltimore. Number three in the overall list has a new name with Dean McGee Eye Institute at the University of Oklahoma, Oklahoma City—the first time that institute has appeared in the top category since the survey’s inception 20 years ago.
Gauging ganciclovir gel for herpes virus
Gauging ganciclovir gel for herpes virusGanciclovir gel is effective for herpes simplex epithelial keratitis, and emerging evidence shows it also can be used to treat other corneal disease.
Imaging, 27-gauge systems capture retina surgeons’ focusRetina surgeons considered 2015 to be an exciting time in the subspecialty in all areas and pointed to the availability and increased use of 27-gauge instrumentation as one of the real highlights of surgical retina.
Year brings advances in retinal imaging, screening, and gene/drug therapiesThe topics of special interest to retina specialists during 2015 include optical coherence tomography angiography (OCTA) and screening for retinopathy of prematurity (ROP). Important research is taking place to determine the etiology of angiogenesis, possibly leading to targeting therapies in age-related macular degeneration (AMD), ROP, and diabetic retinopathy.
DRCR.net retinal treatment results take center stage in 2015Studies of the efficacy of anti-vascular endothelial growth factor (VEGF), gene therapies, and slow-release drug delivery systems took center stage among treatments for retinal disorders in 2015. In addition to studies already under way, others are about to begin.
Big Data transforming glaucoma care, research
What to say when discussing MIGS with patientsWhen microinvasive glaucoma surgery is a potential treatment option, surgeons should present it as neutrally as possible.
Scripps National Spelling Bee champ becomes ophthalmologist for one daySriram Hathwar co-won this year’s 87th Annual Scripps National Spell Bee, but the 14-year-old had another one of his dreams come true Friday—to experience what it is like to be an ophthalmologist for a day.
Dr. Shields to receive national awardJerry A. Shields, MD, director of the Wills Eye Ocular Oncology Service, has been named to receive the National Physician of the Year Award in Clinical Excellence.